AllQuantitative Report
logoArgusJune 09, 2021

PCRX: Lowering target price to $64.00

Symbols
PCRX
Sector(s)
Healthcare
Rating
Current Price
$58.91
Price Target
Earnings Estimate
Summary

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free